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Abstract
Intense fearful behavior and/or intense appetitive eating behavior can be generated by localized amino acid inhibitions along a ro-
strocaudal anatomical gradient within medial shell of nucleus accumbens of the rat. This can be produced by microinjections in
medial shell of either the c-aminobutyric acid (GABA)A agonist muscimol (mimicking intrinsic GABAergic inputs) or the AMPA (a-
amino-3-hydroxy-5-methylisoxazole-4-propionic acid) antagonist DNQX (6,7-dinitroquinoxaline-2,3-dione), disrupting corticolimbic
glutamate inputs). At rostral sites in medial shell, each drug robustly stimulates appetitive eating and food intake, whereas at
more caudal sites the same drugs instead produce increasingly fearful behaviors such as escape, distress vocalizations and
defensive treading (an antipredator behavior rodents emit to snakes and scorpions). Previously we showed that intense motivated
behaviors generated by glutamate blockade require local endogenous dopamine and can be modulated in valence by environ-
mental ambience. Here we investigated whether GABAergic generation of intense appetitive and fearful motivations similarly
depends on local dopamine signals, and whether the valence of motivations generated by GABAergic inhibition can also be
retuned by changes in environmental ambience. We report that the answer to both questions is ‘no’. Eating and fear generated
by GABAergic inhibition of accumbens shell does not need endogenous dopamine. Also, the appetitive/fearful valence generated
by GABAergic muscimol microinjections resists environmental retuning and is determined almost purely by rostrocaudal anatomi-
cal placement. These results suggest that nucleus accumbens GABAergic release of fear and eating are relatively independent of
modulatory dopamine signals, and more anatomically pre-determined in valence balance than release of the same intense behav-
iors by glutamate disruptions.
Introduction
Local inhibitions in medial shell of the nucleus accumbens (NAc) of
the rat produce intense appetitive and/or fearful motivated behaviors
organized along a rostrocaudal gradient resembling an ‘affective
keyboard’. That is, microinjections of either the AMPA (a-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid) antagonist DNQX
(6,7-dinitroquinoxaline-2,3-dione) or c-aminobutyric acid (GABA)
agonist muscimol induce intense appetitive behaviors such as eating
(Maldonado-Irizarry et al., 1995; Stratford & Kelley, 1997), espe-
cially at rostral sites in medial shell (Reynolds & Berridge, 2001,
2002, 2003). Induction of an appetitve psychological state is sup-
ported also by demonstrations that rostral muscimol microinjections
induce conditioned place preference, and potentiate ‘liking’ reactions
to taste (Reynolds & Berridge, 2002; Faure et al., 2010). In contrast,
progressively more caudal microinjections of these same drugs
produce increasingly fearful or aversive behaviors, including distress
vocalizations and escape attempts elicited by the experimenter’s
touch, conditioned place avoidance, and spontaneous emission of
defensive treading/burying behavior, an anti-predator response which
rodents use to throw debris at a localized threat (i.e. rattlesnake or
shock prod) (Coss & Owings, 1978; Treit et al., 1981; Reynolds &
Berridge, 2001, 2002, 2003; Faure et al., 2010). Microinjections at
intermediate locations produce graded mixtures of appetitive and
fearful behaviors.
While keyboard patterns of intense motivations are generated by
both methods of inhibition, GABAergic vs. glutamatergic effects
differ in important respects. For example, while GABAergic musci-
mol microinjection ampliﬁes positive hedonic ‘liking’ reactions to
tastes at rostral sites and conversely ampliﬁes negative disgust reac-
tions at caudal sites (Reynolds & Berridge, 2002; Faure et al.,
2010), glutamate disruption fails to change affective ‘liking’ or dis-
gust reactions, even when DNQX microinjection generates compara-
bly intense levels of appetitive/fearful motivated behaviors (Faure
et al., 2010).
Here we were interested in comparing motivations generated by
GABAergic vs. glutamatergic NAc inhibitions on two other features.
One feature is that endogenous local dopamine is necessary for glu-
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tamate disruptions to generate either desire or dread. That is, mixing
dopamine antagonists into a DNQX microinjection prevents genera-
tion of intense eating and fear (Faure et al., 2008; Richard & Ber-
ridge, 2011). However, given that the GABAergic inhibition
generates changes in hedonic impact as well as motivation, and that
dopamine does not mediate the hedonic impact of tastes (Peci~na
et al., 1997, 2003; Berridge & Robinson, 1998), one might infer
that the GABAergic inhibition should not require dopamine to gen-
erate intense motivations. Is GABAergic generation of eating and
fear independent of local dopamine?
Another feature of the glutamate keyboard is that the ratio of
appetitive to fearful behaviors is retuned by current environmental
ambience, especially at intermediate rostrocaudal ‘keys’. In a famil-
iar and comfortable home environment, DNQX microinjections at
more than 80% of sites generate positive appetitive behavior while
the fear-generating zone shrinks to a far-caudal 20%; by contrast, in
a stressfully loud and bright environment DNQX instead generates
mostly fearful behavior at 80% of sites (Reynolds & Berridge,
2008; Richard & Berridge, 2011). Therefore, we also asked: Is
GABAergic generation of appetitive and fearful motivations simi-
larly retuned by environmental ambience?
Materials and methods
Experimental design
We assessed appetitive and fearful behavior generated by GABAer-
gic inhibition via muscimol microinjections to assess the contribu-
tion of endogenous dopamine signaling, and to detect any inﬂuence
of changes in emotional ambience of the environment. We assessed
the role of endogenous dopamine by combining a D1 antagonist and
D2 antagonist in the same microinjection with the GABAA agonist
muscimol. We separately assessed the inﬂuence of emotional ambi-
ence by comparing motivations generated by muscimol microinjec-
tions or DNQX microinjections in three different environments:
‘Stressful’ (noisy and bright), ‘Standard’ lab and ‘Home’ (a rat’s
own home-room: dark, quiet, familiar odor). To estimate the area of
functional drug spread and to assess the neurobiological impact of
dopamine blockade on GABAergic neuronal suppression, a Fos
plume analysis was conducted on a separate group of rats.
Subjects
Male Sprague–Dawley rats (280–400 g, total n = 95; dopamine
dependence group, n = 18; environment shift groups, n = 59; Fos
Plume group, n = 18) from an in-house breeding colony were
housed on a reversed 12:12-h light–dark cycle at ~21 °C with ad
libitum access to both food and water. All experimental procedures
were approved by the University Committee on the Use and Care of
Animals at the University of Michigan and were carried out in
accordance with the guidelines on animal care and use of the
National Institutes of Health of the United States.
Cranial cannulation surgery
All rats were anesthetized using a mixture of ketamine (80 mg/kg)
and xylazine (5 mg/kg) and pretreated with atropine (0.05 mg/kg) to
prevent respiratory distress. After anesthesia induction, rats were
placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga,
CA, USA), with the mouth bar set to 5.0 mm above intra-aural zero,
so that cannulae could be angled to avoid puncturing the lateral ven-
tricles. Bilateral stainless steel cannulae (14 mm, 23 gauge) were
aimed 2 mm above points throughout the rostrocaudal extent of the
medial shell, between coordinates anteroposterior (AP) +2.4 to
+3.4 mm ahead of bregma, mediolateral (ML)  1.0 mm from the
midline, and dorsoventral (DV), +5.7–6.0 mm below skull. Cannu-
lae were anchored to the skull using surgical screws and secured
with dental cement; stainless steel obturators (28 gauge) were insert
to prevent occlusion of the cannulae. Post-surgery, rats received ce-
fazolin (75 mg/kg) to prevent infection and carprofen (5 mg/kg) for
analgesia. Rats were allowed to recover for 7 days before testing.
Intracerebral microinjections
Drug microinjections were always administered bilaterally in a 0.5-
lL volume on test days spaced at least 48 h apart. On test days,
solutions were brought to room temperature (~21 °C), inspected to
conﬁrm the absence of precipitation, and infused at a speed of
0.3 lL/min using a syringe pump attached via PE-20 tubing to
stainless steel injectors (16 mm, 29 gauge) which extended 2 mm
beyond the end of the guide cannulae into medial shell. Injectors
were left in place for 1 min, and then obturators were replaced and
rats were immediately placed in one of the testing chambers
described below.
GABA/dopamine interaction experiment
For GABAergic muscimol microinjections in medial shell, rats
(n = 18) received a dose of muscimol (75 ng/0.5 lL per side) previ-
ously shown to generate intense eating and fear (Faure et al., 2010).
Muscimol was microinjected either alone or, to test the role of
endogenous dopamine, in combination with two dopamine D1 and
D2 antagonists as a mixture in the same microinjection: the selective
D1 antagonist SCH23390 (R(+)–7-chloro-8-hydroxy-3-methyl 1-phe-
nyl-2,3,4,5,-tetrahydro-1H-3-benzazepine) at a dose of 3 lg/0.5 lL
per side, plus the selective D2 antagonist raclopride (3,5-dichloro-
N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-hydroxy-6-methoxybenza-
mide) at a dose of 5 lg/0.5 lL per side. These doses of dopamine
antagonists have been shown previously to prevent DNQX microin-
jections in NAc shell from producing eating and fearful behaviors
(Faure et al., 2008). Each rat received four microinjections in bal-
anced order: (i) vehicle alone (artiﬁcial cerebrospinal ﬂuid, ACSF),
(ii) muscimol alone, (iii) dopamine antagonists alone (D1 & D2
dopamine antagonists without muscimol) and (iv) muscimol plus D1
& D2 dopamine antagonists. Immediately after every microinjection
the rat was placed in a chamber in a conventional laboratory testing
room with normal daylight illumination conditions (white ﬂuorescent
light intensity 550–650 lux) and moderate intensity ambient noise
(65–70 dB).
GABA vs. glutamate environmental shift experiment
To compare environmental ambience modulation of intense motiva-
tions produced by glutamate disruption or GABA inhibition, each
rat was tested in three different emotional environments either after
DNQX or vehicle microinjections (six tests), or after muscimol or
vehicle microinjection (six tests). DNQX was microinjected at a
dose of 450 ng/0.5 lL per side and muscimol was injected at a dose
of 75 ng/0.5 lL per side, doses which were selected to produce
roughly equal levels of motivated behaviors from previous studies
(Faure et al., 2010). Some rats (n = 29) received microinjections of
either DNQX or its vehicle (50% DMSO and 50% 0.15 M saline)
on separate days, prior to being tested twice each in the Home,
Stressful and Standard environments, for a total of six test days and
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six microinjections per rat. Other rats (n = 30) received microinjec-
tions of either muscimol or its vehicle (ACSF) prior to being tested
twice in each of the three environments, also for a total of six test
days. The order of drug and environment conditions was counterbal-
anced in each group.
The Standard lab environment was identical to test conditions
described above, used in most previous studies and for the dopa-
mine blockade experiment (standard lab room, ﬂuorescent lighting,
low to moderate levels of ambient noise). The Home environment
test occurred in the rats’ own home-room, and was characterized by
dim red lighting (5–10 lux), the familiar odors of the housing room,
and low levels of ambient noise primarily consisting of sound from
the ventilation systems (65–70 dB) and from other rats. The Stress-
ful environment was conducted in an unfamiliar lab room, featuring
high-intensity sensory-stimulation of light and sound. Extra light
was provided by additional incandescent lamps that were directed at
the transparent test chamber (1000–1300 lux within the chamber).
Loud, unpredictable sound was presented continuously through the
test [raucous rock music from the continuous full-album soundtrack
of Raw Power by Iggy & The Stooges (1973; Iggy Pop reissue
1997); 80–86 dB]. In previous preference tests, rats have been
shown to prefer the Home environment condition over the Standard
environment condition and to prefer the Standard lab environment
over the Stressful condition (Reynolds & Berridge, 2008).
Behavioral tests of unconditioned motivated behaviors
Prior to the ﬁrst test day, rats were habituated to handling and pro-
cedures for 7 days: rats were handled for 10 min per day for 3 days,
and then were habituated to the testing procedure and apparatus for
1 h each on four additional days. On the 4th day of habituation rats
received ‘mock’ microinjections of vehicle before being placed in
the chamber. On drug test days, rats received one of the microinjec-
tions described above and were placed immediately in a transparent
testing chamber (23 9 20 9 45 cm) which contained pre-weighed
food (~20 g rats chow) and ad libitum water. The chamber always
contained granular cob bedding (~3 cm deep) to allow expression of
defensive treading behavior. Rats remained in the chamber for
60 min while behavior was videorecorded, to be coded later for
analysis.
At the end of each session, rats were removed by the experi-
menter’s gloved hand using a standardized slow-approach hand
motion in order to quantify any fearful distress calls, escape attempts
or defensive bites elicited by human touch. Following a ~5 s
approach towards the testing cage, the experimenter slowly reached
towards the rat, taking ~2 s. Upon contact, the experimenter lightly
brushed the side of the rat with gloved ﬁngertips, taking ~1 s,
before lifting the rat from the chamber in a gentle movement that
lasted ~2 s. The observer recorded any (i) attempts by the rat to
escape when touched (e.g. frantic jumps or runs away from the
hand), (ii) bites or attempts to bite the gloved hand and (iii) audible
distress vocalizations elicited by the approaching hand.
Behavioral coding of videorecorded behaviors
Videorecorded behaviors were scored ofﬂine by observers blind to
drug conditions. Incidences of elicited fearful distress vocalizations,
escape dashes and bite attempts directed at the experimenter’s hand
were scored when the rat was gently picked up at end of the test
session (Reynolds & Berridge, 2003), at which time the total weight
of chow pellets consumed was also recorded. Behaviors emitted
spontaneously and videotaped during the 1-h test were subsequently
scored by experimenters blind to treatment for the total cumulative
duration (seconds) for each of the following: eating behavior
(involving both appetitive approach and voluntary initiation of
ingestion plus consummatory chewing and swallowing of food),
drinking behaviors (licking from water spout), fearful defensive
treading/burying behavior (deﬁned as active spraying or pushing of
bedding with rapid alternating thrusts of the forepaws, spatially
directed generally towards the brightly lit front or corners of the
cage) and grooming behavior (a stereotyped sequence described in
Aldridge et al., 1993). Observers scored the total number for behav-
iors which tended to occur as discrete events, including appetitive
behaviors such as food carrying (transportation of food pellets in the
mouth) and food sniffs (snifﬁng near the food for at least 1 s), and
two general motor activities: rearing (forepaws at least one inch off
the ﬂoor) and cage crosses (forepaws and head cross the halfway
point of the cage).
Histology
Following behavioral testing rats were killed with an overdose of
sodium pentobarbital, and their brains were removed and ﬁxed in
10% paraformaldehyde for 1–2 days and in 25% sucrose solution
for 3 days. To assess microinjection site locations, brains were
sliced at 60 lm on a freezing microtome, and stained with Cresyl
violet. Microinjection sites were mapped onto coronal slices from a
rat brain atlas (Paxinos & Watson, 2007), which were then used to
extrapolate the position of each site on a sagittal slice. This allowed
for the presentation on the same maps of most of the rostrocaudal
and dorsoventral extent of medial shell. Functional effects on appeti-
tive and fearful behaviors were mapped using color-coding to
express intensity of changes in motivated behaviors for individual
behaviorally tested rats. Symbols were sized to match the maximal
diameter of Fos plumes as found here and previously (Faure et al.,
2010; Richard & Berridge, 2011). For rostral vs. caudal statistical
comparisons, sites were classiﬁed as rostral shell if they were
located more than 1.4 mm ahead of bregma, and as caudal if they
fell behind this benchmark.
Fos-like protein immunohistochemistry
To map the size of the area where microinjections were likely to
have impacted local tissue, as well as to assess the neurobiological
effects of dopamine antagonists on GABA inhibition with muscimol,
we conducted a Fos plume analysis on a separate group of rats after
a single microinjection to detect maximal spread of neural impact.
This was important because we have previously shown that the
intensity and diameter of changes in Fos expression are suppressed
following several DNQX microinjections (Richard & Berridge,
2011). That ﬁnding indicates maximal neural impact spread may
best be assessed after a single microinjection (Richard & Berridge,
2011), just as behavioral efﬁcacy of microinjections may be strong-
est initially (Kelley et al., 2000). Therefore, we analysed Fos after
only a single microinjection to avoid potential mapping problems
due to underestimation of impact spread.
Fos plumes are used speciﬁcally as a measure of diameter for the
spread of neural impact locally surrounding a drug microinjection.
No assumptions are required that Fos-expressing neurons are identi-
cal to receptor-bearing neurons (local neurons that are indirectly
modulated via synaptic recruitment cannot be excluded from con-
tributing to behavioral effects of a microinjection, so are also
included in measures of impact spread), or that Fos-expressing neu-
rons are those functionally responsible for generating an observed
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behavior. Nor do we assume that Fos elevation necessarily signiﬁes
neuronal depolarization or that Fos inhibition signiﬁes hyperpolar-
ization (Dragunow & Faull, 1989). Information regarding the diame-
ter of Fos plumes is useful for identifying how far the immediate
neural impact of a drug microinjection spreads from its center. The
clear spatial cut-off of local continguous Fos plumes allows local
impact spread to be easily distinguished from circuit-level Fos
changes at more distant sites, which are typically separated by unaf-
fected spaces with no change in Fos expression extending up to sev-
eral millimeters from the site. Our study used Fos plumes to
estimate maximal spread of local impact. To construct maps for
localization of function, we combined that information about spread
diameter with functional information about the behavioral conse-
quences of drug microinjections at each mapped site.
Rats used for Fos analysis (n = 18) were anesthetized with an
overdose of sodium pentobarbital and transcardially perfused 90 min
after bilateral microinjection of (i) vehicle in NAc (n = 5), (ii) mu-
scimol (n = 6), (iii) dopamine antagonists (n = 3) or (iv) mixture
(n = 3) or (v) no injection (n = 1) for Fos plumes analysis. Brains
were removed and placed in 4% paraformaldehyde for 4–24 h, and
then transferred to 25% sucrose (in 0.1 M sodium phosphate buffer)
for 3 days. Brains were sliced at 40 lm on a freezing microtome,
and processed for Fos-like immunoreactivity using NDS, goat anti-
cfos (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and donkey
anti-goat Alexa Fluor 488 (Invitrogen, Carlsbad, CA, USA) as
described previously (Faure et al., 2008, 2010; Reynolds & Ber-
ridge, 2008). Sections were mounted, air-dried and coverslipped
with ProLong Gold antifade reagent (Invitrogen).
Fos plume analysis
Immunoreactivity for Fos-like protein was visualized using a Leica
microscope equipped for ﬂuorescent microscopy, using a ﬁlter with
an excitation band at 480–505 nm for Fos-positive cells and images
were taken using MCID Core software. For analysis of drug spread,
Fos plume images were taken in the areas surrounding the microin-
jection with the most intense areas of Fos expression, just caudal to
the end of the injector tip, surrounding a small focal point of necro-
sis. Fos-labeled cells were individually counted within successive
blocks (50 9 50 lm), along eight radial arms emanating from the
center of the necrosis, with 10 9 magniﬁcation (Fig. 1). Zones of
Fos elevation (or ‘plumes’) were assessed as described previously
for muscimol and dopamine antagonist microinjections (Reynolds &
Berridge, 2008). Fos plume estimates of the diameter of DNQX
microinjection impact were adopted from a previous study that used
the same dose and volume of DNQX microinjections in NAc medial
shell (Richard & Berridge, 2011).
Statistical analysis
The effects of dopamine blockade on muscimol-induced motivated
behaviors were assessed using a three-factor mixed within- and
between-subject ANOVA [muscimol 9 dopamine blockade 9 anatom-
ical level (rostral vs. caudal)]. When signiﬁcant effects were found,
rats were split into rostral and caudal groups and additional two-way
(muscimol 9 dopamine blockade) and one-way ANOVAs (main effect
of drug) were conducted, including pairwise comparisons with Sidak
corrections. For analysis of binomial data (vocalizations, escape
attempts and bite attempts) Cochran’s Q and McNemar’s repeated
measures tests were used. The effects of DNQX or muscimol in the
three different emotional environments were compared using
a three-factor mixed within- and between-subjects ANOVA
[drug 9 anatomical level (rostral vs. caudal) 9 environment (Stress-
ful vs. Standard vs. Home)] for all parametric behaviors. When sig-
niﬁcant effects were found, rats were split into rostral and caudal
groups and additional one-way ANOVAs were conducted on the dif-
ference between vehicle and drug between the three environments,
including pairwise comparisons with Sidak corrections. We also
assessed the percentage of rats which met criteria for appetitive,
defensive or mixed valence behaviors, and tested whether that chan-
ged between the three environments for DNQX vs. muscimol, using
Cochran’s Q and McNemar’s repeated-measures test, and whether
the proportion of rats that switched differed between DNQX and
muscimol using Pearson’s chi-squared test.
Results
Dopamine blockade experiment: dopamine is not needed for
GABAergic motivation
Local blockade of dopamine D1 and D2 receptors failed to impair
the ability of GABAergic muscimol microinjections to generate
intense levels of motivated behaviors (5- to 75-times above vehicle
control levels). The generation of neither appetitive eating nor fear-
ful defense/escape behaviors was prevented by the addition of dopa-
mine antagonists to the muscimol microinjection, and muscimol-
generated levels always remained high above vehicle levels regard-
less of whether dopamine antagonists were present or absent (Figs 1
and 2). In rostral shell, muscimol microinjections generated robust
tripling of food intake and of time spent eating, with or without
dopamine antagonists (Figs 1A and B, and 2B; eating, interaction of
muscimol by placement, F1,14 = 14.51, P = 0.002). The addition of
dopamine antagonists did not reduce these intense appetitive behav-
iors generated at rostral sites, and eating remained intense, at more
than double vehicle levels (Figs 1A and 2A; rostral shell, eating,
interaction of muscimol and D1/D2 antagonists, F1,8 = <0.01,
P = 0.996). By comparison, caudal shell sites of muscimol microin-
jection with or without dopamine antagonists generated a 60-fold
increase in defensive treading behavior (Figs 1C and 2B; interaction
of muscimol by placement, F1,14 = 6.15, P = 0.026), as well as dis-
tress vocalizations, escape attempts and sometimes bite attempts in
response to the experimenter’s approach and touch after the treading
test (Figs 1D and 2C; vocalizations and escape attempts,
P < 0.001). Dopamine antagonists did not alter the level of fearful
defensive treading generated by muscimol at caudal sites, which
remained at more than 50-fold vehicle levels (Figs 1C and 2B; inter-
action of muscimol and D1/D2 antagonists, F1,6 = 0.86, P = 0.389).
Dopamine blockade also had no effect on caudal distress vocaliza-
tions, escape attempts or bite attempts observed after the mixture of
muscimol and dopamine antagonists when compared with muscimol
alone (Figs 1D and 2C; McNemar’s test, vocalizations, P = 0.375;
escape attempts, P = 0.180; bite attempts, P = 1.000).
The persistence of intense GABAergic eating and fear after local
dopamine blockade contrasts with the dramatic reduction of motivated
behaviors generated by corticolimbic glutamate disruptions we previ-
ously reported to be caused by similar dopamine blockade (Faure
et al., 2008; Richard & Berridge, 2011). However, by themselves,
microinjection of dopamine antagonists here (without muscimol) did
suppress lower spontaneous baseline levels of appetitive eating and
food intake below vehicle to nearly zero (Figs 1A and B; time spent
eating, general effect of D1/D2 antagonists, F1,15 = 7.853, P = 0.014;
food intake grams consumed, average of 0.25  0.68 g under D1/D2
antagonists vs. 1.65  1.28 g under vehicle; food intake, general
effect of D1/D2 antagonists, F1,15 = 8.674, P = 0.012).
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Appetitive vs. fearful motivational valence generated by
GABAergic inhibition is purely anatomically determined and
resists change by environmental ambience
Muscimol microinjections in NAc shell generated the same rostro-
caudal keyboard-like pattern of intense eating, fearful and mixed
valence behaviors across all three environments, resisting environ-
mental retuning (Figs 3 and 4). At rostral sites in medial shell mu-
scimol generated intense appetitive behavior equally in Home,
Standard and Stressful environments (main effect on eating,
F1,27 = 6.309, P = 0.018; interaction with placement, F2,27 = 5.672,
P = 0.009). At more caudal locations in medial shell, muscimol
generated intense defensive behaviors in all three environments
(main effect on treading, F1,27 = 4.511, P = 0.043; interaction with
placement, F2,27 = 6.388, P < 0.005; Fig. 5), such that at least 46%
of rats emitted distress vocalizations to the experimenter, and at least
21% of rats attempted to escape in each environment (McNemar’s
tests, vocalizations: Standard, P = 0.000, Stressful, P = 0.004,
Home P = 0.000; escape attempts: Standard, P = 0.031, Stressful,
P = 0.008, Home, P = 0.031; Fig. 6). Switching between environ-
ments had no detectable inﬂuence on the intensity of muscimol-elic-
ited appetitive eating at any site (muscimol by environment: eating,
F4,54 = 1.874, P = 0.128; Fig. 7) and did not alter the size of the
appetitive zone in which eating was elicited (Cochran’s Q
(2) = 0.400, P = 0.819). Environmental changes also did not alter
fearful escape attempts or distress vocalizations elicited by the
approach of the experimenter’s gloved hand (vocalizations, Coch-
ran’s Q(2) = 0.500, P = 0.779; escape attempts, Cochran’s Q
(2) = 0.727, P = 0.695), and altered only one category of fearful
reaction: spontaneous defensive treading.
The only environmental modulation effect observed was that the
dark, quiet and familiar Home environment virtually eliminated
spontaneous emission of defensive treading (F1,26 = 8.551,
P < 0.007; McNemar’s tests, vs. Standard, P = 0.005; vs. Stressful,
P = 0.002; Fig. 5). However, the noisy and bright Stressful environ-
ment did not increase defensive treading behavior over the already
intense levels produced by caudal muscimol microinjections in the
Standard environment (muscimol by environment: F1,26 = 0.163,
P = 0.690), and failed to switch any rostral sites from generating
purely appetitive eating to defensive treading (Stressful vs. Standard,
McNemar’s test, P = 1.000). Also, the reactive and even more










































































































Fig. 1. Summary graphs of the effect of local dopamine blockade on muscimol-generated eating and fearful behaviors. Time spent eating (A), amount of food
intake (B), time spent defensive treading/burying (C), as well as incidence of distress vocalizations in response to human touch (D), elicited by vehicle (grey),
dopamine antagonist combination of raclopride and SCH23390 (black), muscimol (red) and mixture of muscimol and dopamine antagonist (yellow) in ros-
tral (n = 9) and caudal (n = 7) regions of medial NAc shell. Errors bars indicate SEM; *P < 0.05, **P < 0.01 change from vehicle, #P < 0.05, ##P < 0.01
change from dopamine antagonists alone, pairwise comparisons using Sidak corrections for multiple comparisons (eating, food intake and defensive treading) or
McNemar’s test (distress vocalizations). Muscimol alone and mixture were never signiﬁcantly different. Summary maps below show the localization of microin-
jections that produced primarily appetitive (green symbols), defensive (red symbols) or mixed appetitive and defensive (yellow symbols) in rostral (white) vs.
caudal (grey) shell.
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Fig. 2. Effects of dopamine antagonism on muscimol-induced eating and defensive fearful behaviors. Fos plume maps (n = 16) of the generation in medial
shell of eating (A), defensive treading (B), and fearful calls, escape attempts and bite attempts (C) by muscimol (left) and a mixture of muscimol plus dopamine
antagonists (right). Local dopamine blockade failed to prevent muscimol-generated eating or fearful behaviors, despite its previously reported ability to prevent
DNQX-induced eating and fear, and its generally suppressive effects. Histograms bars below the maps show behavior as a percentage of vehicle (eating, A;
treading, B) or percentage of subjects (calls, escape attempts and bite attempts, C) for each behavior at rostrocaudal level as marked along the medial shell
(error bars = SEM).
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and escape attempts that were elicited by the experimenter’s touch
remained equally intense and unchanged across all three environ-
ments after caudal muscimol microinjections (distress vocalizations,
Cochran’s Q(2) = 0.500, P = 0.779; escape attempts, Cochran’s Q
(2) = 0.727, P = 0.695; Fig. 6).
Thus, the overall pattern of rostral shell generation of intense eat-
ing, middle generation of mixed eating/fear and caudal generation of
intense fear appeared stable, and determined purely by anatomical
location of each GABAergic microinjection that induced local
hyperpolarization. The valence tuning of individual microinjection
sites rarely shifted across environments. Only the behavioral inten-
sity of spontaneous defensive treading for middle and caudal sites
was at all inﬂuenced by environment, and only by being dampened
in the presence of the familiar and comfortable Home conditions.
All other aspects of intense motivated behaviors generated by
muscimol microinjections were invulnerable to environmental
changes.
By contrast to GABAergic inhibition, the keyboard pattern gener-
ated by DNQX microinjections was powerfully shifted both anatom-
ically and in behavioral intensity generated at particular sites by
changes in environmental ambience, as expected (Figs 3 and 4A;
interaction with environment: eating, F2,44 = 7.359, P = 0.002;
treading, F2,44 = 4.985, P = 0.011; distress vocalizations, Cochran’s
Q(2) = 11.556, P = 0.003; escape attempts, Cochran’s Q(2) =
6.500, P = 0.039). The Stressful environment nearly doubled the
size of the medial shell zone where defensive treading was gener-
ated, in comparison with the Standard environment, to more than
55% of sites (vs. 31% in Standard), more than quadrupling the
defensive zone in comparison with the Home environment (overall
effect of environment on the percentage defensive sites, Cochran’s
Q(2) = 10.391, P = o.006; McNemar’s test, P = 0.002, Fig. 5).
Likewise, the Stressful environment doubled the zone in which
DNQX produced attempts to escape from the experimenter’s hand,
compared with the Standard environment (to 7% of sites; McNe-
mar’s tests, Lab vs. Stressful, P = 0.25; Home vs. Stressful,
P = 0.125; Fig. 6) and quadrupled the zone where DNQX produced
reactive distress vocalizations (to 28%; McNemar’s tests, Lab vs.
Stressful, P = 0.070; Home vs. Stressful, P = 0.008).
Conversely, the familiar Home environment nearly eliminated the
fearful caudal zone where DNQX generated spontaneous defensive
treading behavior (Cochran’s Q(2) = 10.391, P = 0.006; difference
between Stressful and Home environments, McNemar’s test,
P = 0.002, Fig. 5), and completely eliminated generation of reactive
responses such as distress vocalizations and escape attempts to the
experimenter’s hand (McNemar’s test, Lab vs. Home, P = 0.500,
Stressful vs. Home, P = 0.008; Fig. 6). At the same time, the Home
environment expanded the ‘appetitive zone’ where DNQX produced
purely appetitive behavior to more than 75% of medial shell (vs.
31% in the Stressful environment; Fig. 3), consistent with previous
ﬁndings (Reynolds & Berridge, 2008). Testing the Stressful environ-
ment slightly, but non-signiﬁcantly, reduced the intensity of DNQX-
induced eating (DNQX by environment, F1,23 = 3.404, P = 0.078;
Fig. 7).
Fos plume analysis of muscimol and dopamine antagonist
microinjections
Mapping of effects was aided by measurements of drug impact
spread for muscimol microinjections, as reﬂected in Fos plumes of
about 0.5 mm in diameter. Microinjections of muscimol alone in
NAc medial shell altered Fos expression in an area with a total radius
of 0.24 mm: containing a small 0.15-mm-radius excitatory plume
center (volume = 0.014 mm3), of elevated Fos expression (150% of
vehicle levels), encompassed by a larger of 0.24-mm-radius (vol-
ume = 0.06 mm3) inhibitory or ‘anti-plume’ surround (Fos reduced
to < 75% of vehicle levels; Fig. 8), similar to our previous reports
Fig. 3. Summary maps of behavior. Summary maps (A) show behavior produced by muscimol (top) or DNQX (bottom) in either the Home (left), Standard
(middle) or Stressful (right) environments. Each subject (n = 59) was designated as producing primarily appetitive (green symbols), defensive (red symbols) or
mixed appetitive and defensive (yellow symbols) motivated behavior following DNQX microinjection. In a Standard environment, purely appetitive eating
behavior and food intake (criteria for including a site was a > 200% increase in eating) was primarily stimulated in rostral shell by DNQX and muscimol. Fear-
ful distress calls, escape attempts and spontaneous emission of defensive treading-burying (criteria for including a site was a > 500% increase in treading over
vehicle levels, or emission of a defensive reaction to the experimenter) were primarily stimulated in caudal shell by DNQX. Mixed sites met criteria for both
motivations. Testing in the Stressful environment shifted fearful behavior produced by DNQX into more rostral regions, whereas testing in the Home environ-
ment virtually eliminated all defensive behavior produced by DNQX. Muscimol produced a similar rostrocaudal gradient of eating and fear regardless of envi-
ronment.
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(Faure et al., 2010). Dopamine D1 and D2 antagonists, combined
together but without muscimol, produced a tiny excitatory center
(volume = 0.005 mm3) of 150% of vehicle-level Fos expression up
to 0.10 mm from the microinjection center, surrounded by a very
large 0.41-mm-radius robust inhibitory ‘anti-plume’. The anti-plume
contained a dense inhibitory middle layer of 0.16 mm radius (vol-
ume = 0.018 mm3) of intense Fos suppression (< 50% of vehicle
levels), contained within a larger 0.41-mm-radius (vol-
ume = 0.29 mm3) but less intense anti-plume of moderate Fos sup-
pression (50–75% of vehicle levels), consistent with previous reports
(Faure et al., 2008). Combining muscimol and dopamine antagonists
in the same cocktail microinjection produced a similarly sized 0.4-
mm-radius anti-plume, containing an even larger 0.31-mm-radius
middle layer of intense Fos suppression (volume = 0.135 mm3), sur-
rounded by a thinner shell (0.1 mm shell width; 0.4 mm total outer
radius) of moderate Fos suppression (50–75% of vehicle levels; total
volume = 0.24 mm3). The diameter of estimated spread for DNQX
microinjection was based on a previously reported total radius of
0.38 mm ( 0.05 mm, SEM) (Richard & Berridge, 2011).
Discussion
GABAergic release of intense motivations by muscimol microinjec-
tion in NAc appears to be more anatomically predetermined by ro-
strocaudal location in medial shell than equivalent motivation
generation by glutamate disruptions (Reynolds & Berridge, 2008).
GABAergic release of eating and fear is also more autonomous of
endogenous dopamine inputs (Faure et al., 2008; Richard & Ber-
ridge, 2011).
Here the addition of D1 (or D2) dopamine antagonists to GAB-
Aergic muscimol microinjections did not impair the generation of
intense levels of eating and food intake at rostral sites nor of fearful
spontaneous defensive treading behavior and of reactive frantic
escape attempts and distress calls upon being touched at caudal
sites. By contrast, addition of a D1 antagonist to a DNQX microin-
jection does block generation of either eating or fear by NAc gluta-
mate disruption, and addition of a D2 antagonist additionally blocks
generation of fear, as we previously showed (Richard & Berridge,
2011).
Regarding environmental modulation, the valence of appetitive
vs. fearful motivation generated by the GABAergic inhibition of
NAc resisted re-tuning by ambience changes. Muscimol microinjec-
tions always released anatomically determined mixtures of intense
motivations, based solely on keyboard position along the rostrocau-
dal axis of medial shell, regardless of whether rats were exposed to
the comfortable Home environment, the neutral Standard lab, or the
loud and bright Stressful environment. By contrast, we conﬁrmed
that those environmental changes powerfully retuned the relative
size of appetitive vs. fearful valence-generating zones produced by
glutamate disruption.
The sole environmental retuning effect observed for GABAergic
muscimol microinjections was that the dark Home environment
nearly eliminated spontaneous defensive treading-burying, which in
Standard and Stressful environments was directed speciﬁcally
toward the front of the transparent cage. However, reactive distress
calls and frantic escape jumps away from the experimenter’s hand at
the end of the session persisted in the dark Home environment after
caudal muscimol microinjections, remaining unsuppressed, and those
defensive escape reactions elicited by human touch arguably reﬂect
even more intense fear than defensive treading. That pattern sug-
gests that at best the Home environment suppresses moderate fear
generation displayed in defensive treading-burying but does not sup-
press more intense fear generation displayed in reactive distress calls
and frantic escape attempts (elicited by the potentially threatening
stimulus of an approaching human hand). Additionally, an alterna-
tive explanation exists for why spontaneous treading was reduced:
the dark Home environment (illuminated only by dim red light,
which scotopic rat vision does not detect well) made it more difﬁ-
cult for rats to see visual stimuli toward which defensive treading is
usually directed (sight of objects in the room beyond the cage,
reﬂected light from curved corners of the cage). Thus, it may have
been the removal of eliciting visual stimuli that was more responsi-
ble for reducing defensive treading, rather than suppression of fear.
In the lighted Standard and Stressful environments, a rat typically
threw bedding toward the reﬂecting corners or toward the transpar-
ent front wall of the chamber facing the room, often building a
defensive mound of bedding between those stimuli and the rat (Rey-
nolds & Berridge, 2001). In the absence of those eliciting visual
stimuli under darkness, conceivably even an actively fearful rat
might not emit much spontaneous treading behavior, but could still
react defensively to the multi-modal stimulus of an approaching
hand. Especially considering that alternative explanation, and that all
A B
C D
Fig. 4. Maps of changes in motivational valence between the Home and
Stressful environment. Summary maps show sites where DNQX (A) or mu-
scimol (B) generated either intense eating behavior (top; green; > 200% of
vehicle) in the Home environment but not in the Stress environment, or
intense defensive behavior (bottom; red; > 500% of vehicle level treading or
defensive reaction to the experimenter) in the Stressful environment but not
in the Home environment. Sites mapped in white produced the same valence
of behavior in both the Home and the Stressful environment. The criterion
for designating a site as appetitive was a > 200% increase in eating; criteria
for designating a site as defensive was a > 500% increase in treading over
vehicle levels or emission of a defensive reaction to the experimenter. The
percentage of rats that ‘ﬂipped’ between mainly defensive/mixed in the
Stressful environment and purely appetitive in the Home environment was
signiﬁcantly greater in rats that received DNQX (C) than rats that received
muscimol (D), and the number of rats that ‘ﬂipped’ when given muscimol
was not signiﬁcant.
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other aspects of the rostrocaudal pattern of eating and fear generated
by GABA inhibition remained intact across the three environments,
we conclude that GABAergic muscimol generation of intense moti-
vations is more robust, resistant to environmental retuning of
valence and neuroanatomically pre-determined than similar motiva-
tions produced by glutamate disruption (Faure et al., 2008; Rey-
nolds & Berridge, 2008).
Bases for subcortical autonomy
Why should the GABAergic NAc keyboard for generating desire vs.
dread be more anatomically pre-determined and autonomous of
endogenous dopamine than the corresponding glutamatergic key-
board? One possible answer derives from the subcortical and intrin-
sic nature of endogenous GABA signals in NAc, compared with the
corticolimbic nature of glutamate signals. That is, GABA signals
would normally be delivered to spiny neurons in medial shell site
by neighboring intrinsic NAc medium spiny neurons or interneu-
rons, or by GABAergic afferent projections that arose from other
subcortical structures such as ventral pallidum, extended amygdala
(e.g. BNST), lateral hypothalamus or brainstem (Brog et al., 1993;
Sun & Cassell, 1993; Churchill & Kalivas, 1994; Vanbockstaele &
Pickel, 1995; Meredith et al., 2008).
Environmental ambience signals by comparison might ordinarily
be delivered to NAc largely by ‘top-down’ corticolimbic glutamater-
gic projections from prefrontal cortex, or other glutamatergic inputs
from cortex-related structures such as basolateral amygdala, hippo-
campus or thalamus (Beckstead, 1979; Christie et al., 1987; Fuller
et al., 1987; Goldin et al., 2008; Richard & Berridge, 2013). Intrin-
sic subcortical GABA signals therefore might be somewhat ‘bottom-
up’ and relatively autonomous from ‘top-down’ environmental mod-
ulation. By this view of GABAergic autonomy, the resistance of
GABAergic release of appetitive and fearful motivation to changes
in emotional environment reﬂects the resistance of emotional pro-
cesses generated by intrinsically subcortical circuits to top-down
modulation by factors that can inﬂuence corticolimbic regulation of
emotion (Beauregard et al., 2001; Russell, 2003; Davidson, 2004;
Barrett et al., 2007; Posner et al., 2007).
Likewise, while glutamate signals to NAc neurons interact closely
with mesolimbic dopamine signals, often on the same spine (Cepeda
et al., 1993; Calabresi et al., 1997; Brady & O’Donnell, 2004; Tec-
uapetla et al., 2010), GABA signals to NAc neurons may be less
modulated by co-occurring dopamine inputs. Although dopamine
may modify pre-synaptic GABA release from NAc interneurons
(Bracci et al., 2002; Centonze et al., 2002; Tecuapetla et al., 2007;
Towers & Hestrin, 2008), we are aware of no studies reporting that
the post-synaptic hyperpolarizing effects of GABAA receptor activa-
tion on medium spiny neurons are modulated by dopamine. For
example, dopamine transporter knock-down mice, which have
increased levels of dopamine in the synapse, have normal GABA-
receptor-mediated synaptic currents onto striatal medium spiny neu-
rons (Wu et al., 2007). GABAergic generation of eating and fear by
muscimol microinjections may mimic natural post-synaptic GABA
signals that do not depend on post-synaptic dopamine, and so it is
understandable that intense muscimol-generated motivations are not
impaired by blockade of D1 or D2 inputs. The dopamine-indepen-
dent nature of GABAergic eating and fear is also consistent with
subcortical GABAergic generation of ‘liking’ or disgust reactions
that reﬂect intense hedonic impact, psychological processes which
are relatively independent of mesolimbic dopamine (Peci~na et al.,
Fig. 5. Effect of changing environmental ambience on defensive treading produced by DNQX or muscimol. Fos plume maps (n = 59) of the generation of
defensive treading by muscimol (top) or DNQX (bottom) in the Home (left), Standard (middle) or Stressful (right) environments. Testing in the Stressful envi-
ronment had no effect on muscimol-generated treading, but the Home environment nearly eliminated muscimol-generated treading. This may be due to the
removal of all visual cues that the animals usually tread toward. DNQX treading was produced at more rostral locations in a Stressful environment, but was
nearly eliminated by testing in a Home environment. Histogram bars show treading as a percentage of vehicle at each rostrocaudal level as marked along the
medial shell (error bars = SEM).
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1997, 2003; Berridge & Robinson, 1998; Faure et al., 2010). Here,
muscimol microinjection would mimic post-synaptic GABA release
effects by directly binding to GABAA receptors in medial shell, and
hence may have acted downstream of dopamine modulation. This
account of muscimol microinjection effects does not exclude the
possibility that, under natural conditions, changes in dopamine may
modulate motivated behaviors by presynaptic modulation of endoge-
nous GABA release in NAc (Bracci et al., 2002; Centonze et al.,
2002; Tecuapetla et al., 2007; Towers & Hestrin, 2008).
It is also possible that hyperpolarizations produced by GABAergic
muscimol are more robust or intense at the neuronal level than hy-
perpolarizations by DNQX glutamatergic blockade (Koos et al.,
2004), which merely diminishes ‘up states’ to suppress excitatory
postsynaptic potentials (Meredith et al., 1993; Pennartz et al., 1994;
Kiyatkin & Rebec, 1999; Meredith, 1999; O’Donnell, 1999; Suwabe
et al., 2008; Jeun et al., 2009). GABAergic signaling may more
potently inhibit NAc medium spiny neurons by acting directly to
open Cl channels on soma or proximal dendrites (Sun & Cassell,
1993; Johnson et al., 1994; Behrends et al., 2002; Goetz et al.,
2007), whereas glutamatergic AMPA receptors are localized more
distally at the ends of dendrite spines (Meredith et al., 1990; Sesack
& Pickel, 1992; Johnson et al., 1994; Chen et al., 1998), allowing
dopamine released on spines or dendrites to play a greater role.
NAc keyboard pattern
Just as a musical keyboard generates many different notes, depend-
ing on which key is tapped, the NAc ‘affective keyboard’ for gener-
ating desire vs. dread released many different ratios of appetitive to
fearful motivated behaviors depending on the precise rostrocaudal
position of a GABAergic or glutamatergic microinjection. Our data
suggest that the anterior–posterior length of medial shell, which
extends nearly 2.5 mm, contains multiple ‘key’ levels or a ratio con-
tinuum of substrates for opposite motivations. That is, each microin-
jection here released its own individualized ratio of valence-
generating substrates (i.e. either at least three detectable rostrocaudal
levels or a gradual continuum capable of producing many more
potential ratios).
The different ratios appear to be generated by mechanisms con-
tained close to microinjection sites, rather than due to distant drug
diffusion to another part of medial shell. That is suggested espe-
cially by the relatively small diameter of muscimol Fos plumes,
which were just under 0.5 mm (0.24 mm radius), as well as the just
slightly larger diameter of DNQX Fos plumes, just under 0.8 mm
(0.38 mm radius). As a caveat, Fos plumes are not infallible indica-
tors for neurobiological impact spread. However, plumes do at least
provide some objective information on how far a microinjected
drug’s impact may extend. It therefore seems worthwhile to consider
the implications of measured plume spread, at least given the
absence of evidence that muscimol microinjection impact extends
any further. One implication of relatively small 0.5–0.8 mm diame-
ters of impact spread is not only that substrates for both motivations
must have been reachable within that spread from most shell posi-
tions, but also that the different ratio mechanisms must have been
locally contained.
Why can a simpler mechanism not fully account for our effects,
say, in which the front half of the shell simply produced eating and










Fig. 6. Effect of changing environmental ambience on defensive reactions to the experimenter produced by DNQX or muscimol. Fos plume maps (n = 59) of
the generation of defensive reactions to the experimenter by muscimol (top) or DNQX (bottom) in the Home (left), Standard (middle) or Stressful (right) envi-
ronments. Changing environment between the familiar Home or the aversive Stressful environments had no effect on defensive reactions produced by muscimol,
which were robustly generated regardless of environment ambience. In the Stressful environment, defensive reactions to the experimenter produced by DNQX
treading were generated at more rostral locations in shell, but were nearly eliminated by testing in a Home environment. Histogram bars show the percentage of
rats emitting distress calls (yellow), distress calls and escape attempts (red), and distress calls, escape attempts and bite attempts (red) at each rostrocaudal level
as marked along the medial shell.
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Fig. 7. Effect of changing environmental ambience on eating produced by DNQX or muscimol. Fos plume maps (n = 59) of the generation of eating by mu-
scimol (top) or DNQX (bottom) in the Home (left), Standard (middle) or Stressful (right) environments. Changing environmental ambience had inconsistent
effects on eating produced by DNQX or muscimol. Histogram bars show treading as a percentage of vehicle at each rostrocaudal level as marked along the
medial shell (error bars = SEM).
Fig. 8. Fos plume analysis. Fos expression was assessed following microinjections of vehicle, muscimol, dopamine antagonists alone, or a mixture of musci-
mol and dopamine antagonists. Fos-labeled cells were individually counted within successive blocks (50 9 50 lm), along eight radial arms emanating from the
center of the site, with 10 9 magniﬁcation. For vehicle microinjections colors indicate levels of Fos expression of 3 9 (red), and 2 9 (orange) levels of Fos
expression found in normal (uninjected) tissue. For drug microinjections, colors indicate levels of Fos expression of 1.5 9 (yellow), 0.75 9 (light blue) and
0.50 9 (darker blue) vehicle level Fos expression. Line graphs show that muscimol (red) reduced Fos expression approximately ~0.35 mm away from the
microinjection center, and that dopamine antagonists (black) and mixture (yellow) reduced Fos expression from 0.15 mm to 0.40 mm away from the microinjec-
tion center.
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discrete non-overlapping substrates cannot easily account for the
multiple quantitative ratios of appetitive and defensive behavior seen
as sites moved rostral to caudal, or for the capacity for most sites in
medial shell to release both appetitive and fearful motivations. That
is, the two halves of medial shell did not respond as simple qualita-
tive on/off mechanisms. Instead, moves of position along the AP
axis produced proportional shifts in the ratio of intense motivated
behaviors.
Perhaps the most compelling evidence against a simple two-key
mechanism for differently valenced motivations contained in the two
halves of NAc shell are the glutamatergic data which conﬁrmed that
each half of NAc medial shell must also contain at least some sub-
strates for generating its opposite-valenced motivation. That is, the
rostral half of medial shell must also contain at least sparse fear-
releasing substrates, and the caudal shell must also contain at least
sparse eating-releasing substrates. This is demonstrated by the ability
of glutamate-disrupting DNQX microinjections fully contained in
the rostral half of shell to release fear (in a stressful environment),
and for microinjections contained in the caudal half to release eating
(in a comfortable home environment). A qualitative two-mechanism
hypothesis cannot easily explain such reversal patterns.
One way of reconciling all these observations would be to con-
ceive of NAc eating/fear mechanisms as two cloud continuums for
desire/dread substrates extending through medial shell. One substrate
is densest near the rostral pole for generating appetitive eating, but
stretches in declining density nearly to the caudal pole. A second is
densest near the caudal pole for generating fearful responses, but
stretches in declining density nearly to the rostral pole. The two
mechanisms would overlap in varying densities or efﬁcacies
throughout nearly the entire 2.5-mm rostrocaudal extent of medial
shell. As consequence, the ‘affective keyboard’ pattern of behavioral
ratios we observed here would be produced by the relative densities
of substrates within the diameter of each single microinjection along
the AP continuum. Of course, the challenge of identifying what this
actually means in terms of neuronal mechanisms for determining the
valence of intense motivations released by a microinjection remains
a major task for the future.
Disinhibition of rostral vs. caudal NAc shell outputs
The neuronal mechanism by which NAc inhibitions generated moti-
vations is likely to be release or disinhibition of motivation genera-
tors in target structures, as NAc projection neurons are primarily
GABAergic, and would be expected to tonically inhibit downstream
neurons (Taber & Fibiger, 1997; Kelley, 1999; Roitman et al.,
2008; Krause et al., 2010). Temporary inhibition of NAc neurons
by GABAergic muscimol microinjection would remove downstream
GABAergic inhibition, releasing a subpopulation of recipient neu-
rons in a target structure to become relatively excited and generate
intense motivations. Downstream target structures for potential
release include ventral pallidum, ventral tegmentum and lateral
hypothalamus, which all receive GABAergic inputs that originate
throughout the rostrocaudal extent of medial shell (Mogenson et al.,
1983; Zahm & Heimer, 1990; Heimer et al., 1991). Caudal NAc
shell also probably projects to the extended amygdala, including the
central and medial amygdala, the ventrolateral bed nucleus of the
stria terminalis and the sublenticular gray, as well as potentially to
the retrorubral area, the substantia nigra and the parabrachial nucleus
(Heimer et al., 1991; Zahm & Heimer, 1993; Usuda et al., 1998).
Rostral shell projects to speciﬁc targets including particular subre-
gions of the lateral preoptic area, lateral hypothalamus and ventral
pallidum (Usuda et al., 1998; Thompson & Swanson, 2010; Zahm
et al., 2013). Similarly, relative inhibitions of localized NAc neu-
rons by DNQX microinjections, which block excitatory glutamate
inputs to NAc such as from corticolimbic projections, might also
disinhibit distinct subpopulations in target structures to release the
generation of intense motivations. Rostrocaudal differences in poten-
tial targets of release may therefore contribute to different ratios
observed along the NAc rostrocaudal axis in generation of fear vs.
eating.
Conclusions
The NAc generation of intense motivations by localized GABA
inhibition obeys different rules from generation by glutamatergic
disruption regarding dopamine and environmental retuning, even
though GABA inhibition and glutamate disruption both produce
similar appetitive and fearful behaviors organized along the same
NAc rostrocaudal gradient. The GABAergic generation of intense
eating and fearful motivations is solely determined by the anatomi-
cal position of the muscimol microinjections in NAc medial shell.
The valence and intensity of GABAergic appetitive and fearful moti-
vations are relatively immune to modulation by environmental ambi-
ence and free of any need for local dopamine inputs. By contrast,
the keyboard pattern of desire and dread generated by glutamate dis-
ruption is easily retuned by changes in emotional environment, as
well as highly dependent on endogenous dopamine inputs.
This distinction between glutamatergic motivations that are modi-
ﬁable via top-down psychological and mesolimbic dopamine control,
compared with robust GABAergic motivational states that are not,
may have implications for understanding mechanisms of some psy-
chiatric disorders and psychopathologies of emotional well-being.
Flips in the valence of pathologically intense motivational salience
may occur more easily when they primarily involve NAc corticolim-
bic or other glutamatergic mechanisms, than when motivations are
generated by subcortical GABAergic mechanisms that are intrinsic
to NAc. Glutamate/dopamine modiﬁability may relate to why the
incentive salience of amphetamine addiction can ﬂip valence from
appetitive to the fearful salience of amphetamine psychosis, or why
schizophrenic patients can have not only heightened fearful salience
of paranoia but may also show exaggerated incentive salience for
appetitive stimuli (Elman et al., 2006; Featherstone et al., 2007;
Jensen et al., 2008; Howes & Kapur, 2009). In contrast, motivations
released by GABAergic inhibitions in NAc-related circuits may be
more anatomically coded, consistently valenced, hedonically laden
and less amenable to regulation by top-down control (Faure et al.,
2010; Watson & Naragon-Gainey, 2010).
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